This article explains the potential of stem cell therapies in lupus treatment, focusing on mesenchymal stem cells (MSCs). This article discusses how MSCs can help repair damaged tissue and modulate the immune response, particularly for patients with severe or refractory lupus. Although the FDA has not yet approved stem cell therapy for lupus, ongoing clinical trials are promising.
Menu
